Hearings start in the generic pharmaceutical industry's legal challenge of extended market monopolies for brand name drugs in the Federal Court of Canada.
Canada's largest manufacturer and distributor of advanced natural health products recently announced its commitment to a rigorous new set of quality-control benchmarks.
